{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:56:21Z","timestamp":1784894181200,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2018\/1845-4"],"award-info":[{"award-number":["2018\/1845-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2018\/00172-0"],"award-info":[{"award-number":["2018\/00172-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2015\/21072-5"],"award-info":[{"award-number":["2015\/21072-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2016\/15603-0"],"award-info":[{"award-number":["2016\/15603-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2016\/15603-0"],"award-info":[{"award-number":["2016\/15603-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2016\/00696-3"],"award-info":[{"award-number":["2016\/00696-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2017\/07725-1"],"award-info":[{"award-number":["2017\/07725-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2018\/18545-4"],"award-info":[{"award-number":["2018\/18545-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/00172-0"],"award-info":[{"award-number":["2018\/00172-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/21072-5"],"award-info":[{"award-number":["2015\/21072-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/15603-0"],"award-info":[{"award-number":["2016\/15603-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/00696-3"],"award-info":[{"award-number":["2016\/00696-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/007725-1"],"award-info":[{"award-number":["2017\/007725-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAPES\/CNPq","award":["01"],"award-info":[{"award-number":["01"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is associated with lipid derangements that worsen kidney function and enhance cardiovascular (CVD) risk. The management of dyslipidemia, hypertension and other traditional risk factors does not completely prevent CVD complications, bringing up the participation of nontraditional risk factors such as advanced glycation end products (AGEs), carbamoylation and changes in the HDL proteome and functionality. The HDL composition, proteome, chemical modification and functionality were analyzed in nondialysis subjects with DKD categorized according to the estimated glomerular filtration rate (eGFR) and urinary albumin excretion rate (AER).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Individuals with DKD were divided into eGFR&gt;\u200960\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      plus AER stages A1 and A2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) and eGFR&lt;\u200960 plus A3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925) and matched by age with control subjects (eGFR&gt;\u200960;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Targeted proteomic analyses quantified 28 proteins associated with HDL in all groups, although only 2 were more highly expressed in the eGFR&lt;\u200960\u2009+\u2009A3 group than in the controls: apolipoprotein D (apoD) and apoA-IV. HDL from the eGFR&lt;\u200960\u2009+\u2009A3 group presented higher levels of total AGEs (20%), pentosidine (6.3%) and carbamoylation (4.2 x) and a reduced ability to remove\n                      <jats:sup>14<\/jats:sup>\n                      C-cholesterol from macrophages (33%) in comparison to HDL from controls. The antioxidant role of HDL (lag time for LDL oxidation) was similar among groups, but HDL from the eGFR&lt;\u200960\u2009+\u2009A3 group presented a greater ability to inhibit the secretion of IL-6 and TNF-alpha (95%) in LPS-elicited macrophages in comparison to the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The increase in apoD and apoA-IV could contribute to counteracting the HDL chemical modification by AGEs and carbamoylation, which contributes to HDL loss of function in well-established DKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-020-01381-w","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:02:41Z","timestamp":1600030961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Monique F. M.","family":"Santana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00e9cio L. A.","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael S.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Minanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R. M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I. B. A. C.","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna R.","family":"Nakandakare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L. C.","family":"Correa-Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia S.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella E.","family":"Ronsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-4698","authenticated-orcid":false,"given":"Marisa","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"1381_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semnephrol.2018.02.003","volume":"38","author":"M Maqbool","year":"2018","unstructured":"Maqbool M, Cooper ME, Jandeleit-Dahm KAM. Cardiovascular disease and diabetic kidney disease. Semin Nephrol. 2018;38:217\u201332.","journal-title":"Semin Nephrol"},{"key":"1381_CR2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","volume":"93","author":"N Rabbani","year":"2018","unstructured":"Rabbani N, Thornalley PJ. Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 2018;93:803\u201313.","journal-title":"Kidney Int"},{"key":"1381_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2018.08.067","volume":"210","author":"V Ravarotto","year":"2018","unstructured":"Ravarotto V, Simioni F, Pagnin E, Davis AP, Cal\u00f2 AL. Oxidative stress - chronic kidney disease - cardiovascular disease: a vicious circle. Life Sci. 2018;210:125\u201331.","journal-title":"Life Sci"},{"key":"1381_CR4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrneph.2017.103","volume":"13","author":"S Delanghe","year":"2017","unstructured":"Delanghe S, Delanghe JR, Speeckaert R, Biesen VW, Speeckaert MM. Mechanisms and consequences of carbamoylation. Nat Rev Nephrol. 2017;13:580\u201393.","journal-title":"Nat Rev Nephrol"},{"key":"1381_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diab.43.5.649","volume":"43","author":"C Tsalamandris","year":"1994","unstructured":"Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes. 1994;43:649\u201355.","journal-title":"Diabetes"},{"key":"1381_CR6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.diabet.2012.04.001","volume":"38","author":"JM Halimi","year":"2012","unstructured":"Halimi JM. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes Metab. 2012;38:291\u20137.","journal-title":"Diabetes Metab"},{"key":"1381_CR7","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"1381_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/dmrr.2362","volume":"29","author":"A Machado-Lima","year":"2013","unstructured":"Machado-Lima A, Iborra RT, Pinto RS, Sartori CH, Oliveira RE, Nakandakare ER, et al. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport. Diabetes Metab Res Rev. 2013;29:66\u201376.","journal-title":"Diabetes Metab Res Rev"},{"key":"1381_CR9","first-page":"1485","volume":"2012","author":"LS Okuda","year":"1821","unstructured":"Okuda LS, Castilho G, Rocco DDFM, Nakandakare ER, Catanozi S, Passarelli M. Advanced glycated albumin impairs HDL anti-inflammatory activity and primes macrophages for inflammatory response that reduces reverse cholesterol transport. Biochim Biophys Acta. 1821;2012:1485\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"1381_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","volume":"224","author":"J Jiang","year":"2012","unstructured":"Jiang J, Chen P, Chen JH, Yu X, Xie D, Mei C, et al. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis. Atherosclerosis. 2012;224:187\u201394.","journal-title":"Atherosclerosis"},{"key":"1381_CR11","doi-asserted-by":"publisher","unstructured":"Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: much more than lipid transporters. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030732.","DOI":"10.3390\/ijms21030732"},{"key":"1381_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"1381_CR13","first-page":"12","volume":"17","author":"H Pageon","year":"2007","unstructured":"Pageon H, Bakala H, Monnier VM, Asselineau D. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol. 2007;17:12\u201320.","journal-title":"Eur J Dermatol"},{"key":"1381_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/acs.jproteome.9b00511","volume":"19","author":"ARM Silva","year":"2020","unstructured":"Silva ARM, Toyoshima MTK, Passarelli M, Di Mascio P, Ronsein GE. Comparing data-independent acquisition and parallel reaction monitoring in their abilities to differentiate high-density lipoprotein subclasses. J Proteome Res. 2020;19:248\u201359.","journal-title":"J Proteome Res"},{"key":"1381_CR15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2019","unstructured":"MacLean B, Tomazela DM, Shulman N, Finney MCGL, Frewen B, Kern R, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2019;26:966\u20138.","journal-title":"Bioinformatics"},{"key":"1381_CR16","doi-asserted-by":"crossref","unstructured":"Basu SK, Goldstein JL, Anderson and Brown RGWMS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts Proc Natl Acad Sci U S A 1976;73:3178\u20133182.","DOI":"10.1073\/pnas.73.9.3178"},{"key":"1381_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-1759(95)00136-X","volume":"184","author":"MD Englen","year":"1995","unstructured":"Englen MD, Valdez YE, Lehnert NM, Lehnert BE. Granulocyte\/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J Immunol Methods. 1995;184:281\u20133.","journal-title":"J Immunol Methods"},{"key":"1381_CR18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1600-0838.2007.00748.x","volume":"18","author":"RT Iborra","year":"2008","unstructured":"Iborra RT, Ribeiro ICD, Neves MQTS, Charf AM, Lottenberg SA, Negr\u00e3o CE, et al. Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand J Med Sci Sports. 2008;18:742\u201350.","journal-title":"Scand J Med Sci Sports"},{"key":"1381_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, Van Der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93\u2013104.","journal-title":"Kidney Int"},{"key":"1381_CR20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1681\/ASN.2017070798","volume":"29","author":"F Kronenberg","year":"2018","unstructured":"Kronenberg F. HDL in CKD \u2013 the devil is in the detail. J Am Soc Nephrol. 2018;29:1356\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"1381_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4161\/cc.9.2.10433","volume":"9","author":"J Muffat","year":"2010","unstructured":"Muffat J, Walker DW. Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle. 2010;9:269\u201373.","journal-title":"Cell Cycle"},{"key":"1381_CR22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/bioinformatics\/btp073","volume":"25","author":"JP de Magalh\u00e3es","year":"2009","unstructured":"de Magalh\u00e3es JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009;25:875\u201381.","journal-title":"Bioinformatics"},{"key":"1381_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.mp.4001223","volume":"8","author":"EA Thomas","year":"2003","unstructured":"Thomas EA, Dean B, Scarr E, Copolov D, Sutcliffe JG. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Mol Psychiatry. 2003;8:167\u201375.","journal-title":"Mol Psychiatry"},{"key":"1381_CR24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1566524033479681","volume":"3","author":"EA Thomas","year":"2003","unstructured":"Thomas EA, Copolov DL, Sutcliffe JG. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr Mol Med. 2003;3:408\u201318.","journal-title":"Curr Mol Med"},{"key":"1381_CR25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1474-9726.2008.00395.x","volume":"7","author":"MD Ganfornina","year":"2008","unstructured":"Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell. 2008;7:506\u201315.","journal-title":"Aging Cell"},{"key":"1381_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18632\/aging.100004","volume":"1","author":"G Perdomo","year":"2009","unstructured":"Perdomo G, Henry DH. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging. 2009;1:17\u201327.","journal-title":"Aging"},{"key":"1381_CR27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","volume":"117","author":"T Vaisar","year":"2007","unstructured":"Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, et al. Shotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDL. J Clin Invest. 2007;117:746\u201356.","journal-title":"J Clin Invest"},{"key":"1381_CR28","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/01.ATV.0000100404.05459.39","volume":"23","author":"JM Sarjeant","year":"2003","unstructured":"Sarjeant JM, Lawrie A, Kinnear C, Yablonsky S, Leung W, Massaeli H, et al. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1\/2 to the nucleus. Arterioscler Thromb Vasc Biol. 2003;23:2172\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1381_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOL.0000000000000371","volume":"28","author":"F Kronenberg","year":"2017","unstructured":"Kronenberg F. Apolipoprotein. L1 and apolipoprotein A-IV and their association with kidney function. Curr Opin Lipidol. 2017;28:39\u201345.","journal-title":"Curr Opin Lipidol"},{"key":"1381_CR30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2796.2012.02585.x","volume":"272","author":"B Kollerits","year":"2012","unstructured":"Kollerits B, Krane V, Drechsler C, M\u00e4rz W, Ritz E, Wanner C, et al. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D study. J Intern Med. 2012;272:592\u2013600.","journal-title":"J Intern Med"},{"key":"1381_CR31","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1016\/S0021-9258(19)39010-6","volume":"265","author":"A Steinmetz","year":"1990","unstructured":"Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I\/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem. 1990;265:7859\u201363.","journal-title":"J Biol Chem"},{"key":"1381_CR32","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/S0021-9258(19)39557-2","volume":"265","author":"IJ Goldberg","year":"1990","unstructured":"Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein apoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem. 1990;265:4266\u201372.","journal-title":"J Biol Chem"},{"key":"1381_CR33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0022-2275(20)40111-7","volume":"35","author":"V Guyard-Dangremont","year":"1994","unstructured":"Guyard-Dangremont V, Lagrost L, Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res. 1994;35:982\u201392.","journal-title":"J Lipid Res"},{"key":"1381_CR34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.prostaglandins.2018.10.004","volume":"139","author":"J Peng","year":"2018","unstructured":"Peng J, Xiang-Ping L. Apolipoprotein A-IV: a potential therapeutic target for atherosclerosis. Prostag Lipid Mediators. 2018;139:87\u201392.","journal-title":"Prostag Lipid Mediators"},{"key":"1381_CR35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.273.5277.966","volume":"273","author":"N Duverger","year":"1996","unstructured":"Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, et al. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 1996;273:966\u20138.","journal-title":"Science"},{"key":"1381_CR36","doi-asserted-by":"publisher","unstructured":"Okuda LS, Iborra RT, Pinto PR, Machade UF, Giannella-Corr\u00eaa ML, Pickford R, et al. Advanced glvcated apoA-IV loses its abilitv to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages. Mediat Inflamm. 2020. https:\/\/doi.org\/10.1155\/2020\/6515401.","DOI":"10.1155\/2020\/6515401"},{"key":"1381_CR37","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","volume":"30","author":"E Nob\u00e9court","year":"2010","unstructured":"Nob\u00e9court E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, et al. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol. 2010;30:766\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1381_CR38","doi-asserted-by":"crossref","first-page":"e34107","DOI":"10.1371\/journal.pone.0034107","volume":"7","author":"A Mang\u00e9","year":"2012","unstructured":"Mang\u00e9 A, Goux A, Badiou S, Patrier L, Canaud B, Maudelond T, et al. HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach. PLoS One. 2012;7:e34107.","journal-title":"PLoS One"},{"key":"1381_CR39","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","volume":"22","author":"M Holzer","year":"2011","unstructured":"Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C, et al. Uremia alters HDL composition and function. J Am Soc Nephrol. 2011;22:1631\u201341.","journal-title":"J Am Soc Nephrol"},{"key":"1381_CR40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/toxins11110671","volume":"11","author":"N Florens","year":"2019","unstructured":"Florens N, Calzada C, Delolme F, Adeline P, Egziabher FG, Juilard L, et al. Proteomic characterization of high-density lipoprotein particles from non-diabetic hemodialysis patients. Toxins. 2019;11:671.","journal-title":"Toxins"},{"key":"1381_CR41","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1021\/acs.jproteome.5b00060","volume":"14","author":"B Shao","year":"2015","unstructured":"Shao B, De Boer I, Tang C, Mayer P, Zelnick L, Afkarian M, et al. A cluster of proteins implicated in kidney disease is increased in high-density lipoprotein isolated from hemodialysis subjects. J Proteome Res. 2015;14:2792\u2013806.","journal-title":"J Proteome Res"},{"key":"1381_CR42","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/ATVBAHA.119.312556","volume":"39","author":"B Shao","year":"2019","unstructured":"Shao B, Zelnick LR, Wimberger J, Himmelfarb J, Brunzell J, Davidson WS, et al. Albuminuria, the high-density lipoprotein proteome, and coronary artery calcification in type 1 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2019;39:1483\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1381_CR43","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2215\/CJN.11321017","volume":"13","author":"K Wang","year":"2018","unstructured":"Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM. Imrey, et al. alteration of HDL protein composition with hemodialysis initiation. Clin J Am Soc Nephrol. 2018;13:1225\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1381_CR44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.diabet.2017.05.006","volume":"44","author":"C Nicolas","year":"2018","unstructured":"Nicolas C, Jaisson S, Gorisse L, Tessier FJ, Niquet-L\u00e9ridon C, Jacolot P, et al. Carbamylation is a competitor of glycation for protein modification in vivo. Diabetes Metab. 2018;44:160\u20137.","journal-title":"Diabetes Metab"},{"key":"1381_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12882-018-0814-8","volume":"19","author":"R Kaseda","year":"2018","unstructured":"Kaseda R, Tsuchida Y, Yang HC, Yancey PG, Zhong J, Tao H, et al. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism. BMC Nephrol. 2018;19:17.","journal-title":"BMC Nephrol"},{"key":"1381_CR46","first-page":"27","volume":"5","author":"J Cornoni-Huntley","year":"1993","unstructured":"Cornoni-Huntley J, Ostfeld AM, Taylor JO, Wallace RB, Blazer D, Berkman LF, et al. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging. 1993;5:27\u201337.","journal-title":"Aging"},{"key":"1381_CR47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-126-10-199705150-00001","volume":"126","author":"MC Corti","year":"1997","unstructured":"Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glunn RJ, Havlik RJ. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997;126:753\u201360.","journal-title":"Ann Intern Med"},{"key":"1381_CR48","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","volume":"60","author":"S Yamamoto","year":"2012","unstructured":"Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, KAseda R, Cox B, et al. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol. 2012;60:2372\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1381_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.06.005","volume":"136","author":"SM Meier","year":"2015","unstructured":"Meier SM, Wultsch A, Hollaus M, Ammann M, Pemberger E, Liebscher F, et al. Effect of chronic kidney disease on macrophage cholesterol efflux. Life Sci. 2015;136:1\u20136.","journal-title":"Life Sci"},{"key":"1381_CR50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2018.01.037","volume":"270","author":"R Maeba","year":"2018","unstructured":"Maeba R, Kojima KI, Nagura M, Komori A, Noshimukai M, Okazaki T, et al. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: a cross-sectional study in chronic kidney disease patients. Atherosclerosis. 2018;270:102\u20139.","journal-title":"Atherosclerosis"},{"key":"1381_CR51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2017.05.001","volume":"112","author":"A Ganda","year":"2017","unstructured":"Ganda A, Yvan-Charvet L, Zhang Y, Lai EJ, Shenk RR, Hussain FN, et al. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD. J Mol Cell Cardiol. 2017;112:114\u201322.","journal-title":"J Mol Cell Cardiol"},{"key":"1381_CR52","doi-asserted-by":"crossref","first-page":"0163826","DOI":"10.1371\/journal.pone.0163826","volume":"11","author":"A Machowska","year":"2016","unstructured":"Machowska A, Sun J, Qureshi AR, Isoyama N, Leurs P, Anderstam B, et al. Plasma pentosidine and its association with mortality in patients with chronic kidney disease. PLoS One. 2016;11:0163826.","journal-title":"PLoS One"},{"key":"1381_CR53","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","volume":"14","author":"M Holzer","year":"2011","unstructured":"Holzer M, Gauster M, Pfeifer T, Wadsack C, Fauler G, Stiegler P, et al. Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Sign. 2011;14:2337\u201346.","journal-title":"Antioxid Redox Sign"},{"key":"1381_CR54","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2011.4403","volume":"17","author":"M Holzer","year":"2012","unstructured":"Holzer M, Zangger K, El-Gamal D, Binder V, Curcic S, Konya V, et al. Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein. Antioxid Redox Sign. 2012;17:1043\u201352.","journal-title":"Antioxid Redox Sign."},{"key":"1381_CR55","doi-asserted-by":"publisher","unstructured":"Rysz J, Gluba-Brz\u00f3zka A, Rysz-G\u00f3rzy\u0144ska M, Franczyk B. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21020601.","DOI":"10.3390\/ijms21020601"},{"key":"1381_CR56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2423(10)51002-3","volume":"51","author":"AG Basnakian","year":"2010","unstructured":"Basnakian AG, Shah SV, Ok E, Altunel E, Apostolov EO. Carbamylated LDL. Adv Clin Chem. 2010;51:25\u201352.","journal-title":"Adv Clin Chem"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01381-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-020-01381-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01381-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T21:55:43Z","timestamp":1668722143000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01381-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1381"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01381-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v6","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33407\/v2","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were properly informed about the procedures and the study and signed an informed written consent form that was previously approved by The Ethical Committee for Human Research Protocols of the Clinical Hospital (#15024), in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest. All authors have read and approved the submission of the manuscript; the manuscript has not been published and is not being considered for publication elsewhere, in whole or in part, in any language.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}